Abstract
Background: Differences in the impact of the 1- or 2-stent strategy in similar coronary bifurcation lesion conditions are not well understood. This study investigated the clinical outcomes and its predictors between 1 or 2 stents in propensity score-matched (PSM) complex bifurcation lesions. Methods and Results: We analyzed the data of patients with bifurcation lesions, obtained from a multicenter registry of 2,648 patients (median follow up, 53 months). The patients were treated by second generation drug-eluting stents (DESs). The primary outcome was target lesion failure (TLF), composite of cardiac death, target vessel myocardial infarction (TVMI), and ischemia-driven target lesion revascularization (TLR). PSM was performed to balance baseline clinical and angiographic discrepancies between 1 and 2 stents. After PSM (N=333 from each group), the 2-stent group had more TLRs (hazard ratio [HR] 3.14, 95% confidence interval [CI] 1.42-6.97, P=0.005) and fewer hard endpoints (composite of cardiac death and TVMI; HR 0.44, 95% CI 0.19-1.01, P=0.054), which resulted in a similar TLF rate (HR 1.40, 95% CI 0.83-2.37, P=0.209) compared to the 1-stent group. Compared with 1-stent, the 2-stent technique was more frequently associated with less TLF in the presence of main vessel (pinteraction=0.008) and side branch calcification (pinteraction=0.010). Conclusions: The 2-stent strategy should be considered to reduce hard clinical endpoints in complex bifurcation lesions, particularly those with calcifications.
Original language | English |
---|---|
Pages (from-to) | 1365-1375 |
Number of pages | 11 |
Journal | Circulation Journal |
Volume | 86 |
Issue number | 9 |
DOIs | |
Publication status | Published - 2022 |
Bibliographical note
Funding Information:This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF - 2021R1A5A2030333). We thank Jin-Seob Kim, MD, MPH for his statistical support. This work was supported by the Korean Bifurcation Club and the Korean Society of Interventional Cardiology.
Funding Information:
The COBIS (Coronary Bifurcation Stenting) III registry is a retrospective, multicenter, observational, and real-world registry that consecutively enrolled patients with bifurcation lesions who underwent percutaneous coronary intervention (PCI) using a second generation DES (Clinicaltrials. gov, NCT03068494).9 A total of 2,648 patients were consecutively enrolled across 21 centers in the Republic of Korea between January 2010 and December 2014. The inclusion and exclusion criteria were as described previously.9 This registry was supported by the Korean Bifurcation Club and the Korean Society of Interventional Cardiology. Written informed consent was waived by each institutional review board due to the retrospective nature of the study. The current study was approved by institutional review boards (IRBs) from each participating centers, including the IRB of our own institute (Gachon University Gil Medical Center; IRB approval number: GBIRB2017-070).
Publisher Copyright:
© 2022 Japanese Circulation Society. All rights reserved.
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine